PubMed:32246317 / 1014-1146 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-sentences-v1

    {"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":132},"obj":"Sentence"}],"text":"The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer \u003e 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017)."}

    LitCovid-TimeML

    {"project":"LitCovid-TimeML","denotations":[{"id":"tok217","span":{"begin":0,"end":3},"obj":"DT"},{"id":"tok218","span":{"begin":4,"end":6},"obj":"CD"},{"id":"tok219","span":{"begin":6,"end":7},"obj":":"},{"id":"tok220","span":{"begin":7,"end":10},"obj":"NN"},{"id":"tok221","span":{"begin":11,"end":20},"obj":"NN"},{"id":"tok222","span":{"begin":21,"end":23},"obj":"IN"},{"id":"tok223","span":{"begin":24,"end":31},"obj":"NN"},{"id":"tok224","span":{"begin":32,"end":37},"obj":"NNS"},{"id":"tok225","span":{"begin":38,"end":42},"obj":"VBD"},{"id":"tok226","span":{"begin":43,"end":48},"obj":"JJR"},{"id":"tok227","span":{"begin":49,"end":53},"obj":"IN"},{"id":"tok228","span":{"begin":54,"end":62},"obj":"NNS"},{"id":"tok229","span":{"begin":63,"end":65},"obj":"IN"},{"id":"tok230","span":{"begin":66,"end":71},"obj":"NNP"},{"id":"tok231","span":{"begin":72,"end":77},"obj":"NN"},{"id":"tok232","span":{"begin":78,"end":82},"obj":"IN"},{"id":"tok233","span":{"begin":83,"end":85},"obj":"NNP"},{"id":"tok234","span":{"begin":85,"end":90},"obj":"NN"},{"id":"tok235","span":{"begin":91,"end":92},"obj":"NN"},{"id":"tok236","span":{"begin":93,"end":94},"obj":"CD"},{"id":"tok237","span":{"begin":94,"end":95},"obj":"."},{"id":"tok238","span":{"begin":95,"end":96},"obj":"CD"},{"id":"tok239","span":{"begin":97,"end":99},"obj":"NN"},{"id":"tok240","span":{"begin":99,"end":100},"obj":"NN"},{"id":"tok241","span":{"begin":100,"end":102},"obj":"NN"},{"id":"tok242","span":{"begin":103,"end":104},"obj":"("},{"id":"tok243","span":{"begin":104,"end":106},"obj":"CD"},{"id":"tok244","span":{"begin":106,"end":107},"obj":"."},{"id":"tok245","span":{"begin":107,"end":108},"obj":"CD"},{"id":"tok246","span":{"begin":108,"end":109},"obj":"NN"},{"id":"tok247","span":{"begin":110,"end":112},"obj":"NNS"},{"id":"tok248","span":{"begin":112,"end":113},"obj":"."},{"id":"tok249","span":{"begin":114,"end":116},"obj":"CD"},{"id":"tok250","span":{"begin":116,"end":117},"obj":"."},{"id":"tok251","span":{"begin":117,"end":118},"obj":"CD"},{"id":"tok252","span":{"begin":118,"end":119},"obj":"NN"},{"id":"tok253","span":{"begin":119,"end":120},"obj":","},{"id":"tok254","span":{"begin":121,"end":122},"obj":"NN"},{"id":"tok255","span":{"begin":123,"end":124},"obj":"SYM"},{"id":"tok256","span":{"begin":125,"end":126},"obj":"CD"},{"id":"tok257","span":{"begin":126,"end":127},"obj":"."},{"id":"tok258","span":{"begin":127,"end":130},"obj":"CD"},{"id":"tok259","span":{"begin":130,"end":131},"obj":")"},{"id":"tok260","span":{"begin":131,"end":132},"obj":"."},{"id":"lookup14","span":{"begin":7,"end":10},"obj":"date_unit"},{"id":"lookup15","span":{"begin":108,"end":109},"obj":"percent"},{"id":"lookup16","span":{"begin":118,"end":119},"obj":"percent"}],"text":"The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer \u003e 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017)."}

    LitCovid-PD-FMA-UBERON-v1

    {"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T2","span":{"begin":24,"end":31},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer \u003e 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017)."}

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T15","span":{"begin":24,"end":31},"obj":"CHEBI:24505"},{"id":"T16","span":{"begin":24,"end":31},"obj":"CHEBI:24505"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer \u003e 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017)."}

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T7","span":{"begin":0,"end":132},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":132},"obj":"Sentence"}],"text":"The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer \u003e 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017)."}